Search research articles
Contact Us
Filters
Showing results (21-30 of 295) with videos related to
Page
of 30
Sort By:
Expert Opinion on Therapeutic Targets
|
August 4, 2015
Bacterial, fungal and protozoan carbonic anhydrases as drug targets
Clemente Capasso, Claudiu T Supuran
The Enzymes
|
November 14, 2025
Coronaviruses main proteases and their inhibitors
Claudiu T Supuran, Clemente Capasso
Expert Opinion on Therapeutic Patents
|
July 6, 2018
Biomedical applications of prokaryotic carbonic anhydrases
Claudiu T Supuran, Clemente Capasso
Expert Opinion on Therapeutic Patents
|
April 20, 2023
The management of <i>Babesia</i>, amoeba and other zoonotic diseases provoked by protozoa
Clemente Capasso, Claudiu T Supuran
Expert Opinion on Therapeutic Patents
|
March 16, 2013
Anti-infective carbonic anhydrase inhibitors: a patent and literature review
Clemente Capasso, Claudiu T Supuran
Pathogens (Basel, Switzerland)
|
July 18, 2017
Carbonic Anhydrase from Porphyromonas Gingivalis as a Drug Target
Claudiu T Supuran, Clemente Capasso
Journal of Enzyme Inhibition and Medicinal Chemistry
|
April 29, 2014
An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?
Clemente Capasso, Claudiu T Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry
|
September 6, 2021
An overview on the recently discovered iota-carbonic anhydrases
Alessio Nocentini, Claudiu T Supuran, Clemente Capasso
The Enzymes
|
October 8, 2025
Sordaria macrospora carbonic anhydrases
Niccolò Paoletti, Claudiu T Supuran, Clemente Capasso
Expert Opinion on Drug Discovery
|
March 14, 2022
Perspectives on the design and discovery of α-ketoamide inhibitors for the treatment of novel coronavirus: where do we stand and where do we go?
Alessio Nocentini, Clemente Capasso, Claudiu T Supuran
Page
of 30
Search research articles
Search
Showing results (21-30 of 295) with videos related to
Sort By:
Page
of 30
Expert Opinion on Therapeutic Targets
|
August 4, 2015
Bacterial, fungal and protozoan carbonic anhydrases as drug targets
Clemente Capasso, Claudiu T Supuran
The Enzymes
|
November 14, 2025
Coronaviruses main proteases and their inhibitors
Claudiu T Supuran, Clemente Capasso
Expert Opinion on Therapeutic Patents
|
July 6, 2018
Biomedical applications of prokaryotic carbonic anhydrases
Claudiu T Supuran, Clemente Capasso
Expert Opinion on Therapeutic Patents
|
April 20, 2023
The management of <i>Babesia</i>, amoeba and other zoonotic diseases provoked by protozoa
Clemente Capasso, Claudiu T Supuran
Expert Opinion on Therapeutic Patents
|
March 16, 2013
Anti-infective carbonic anhydrase inhibitors: a patent and literature review
Clemente Capasso, Claudiu T Supuran
Pathogens (Basel, Switzerland)
|
July 18, 2017
Carbonic Anhydrase from Porphyromonas Gingivalis as a Drug Target
Claudiu T Supuran, Clemente Capasso
Journal of Enzyme Inhibition and Medicinal Chemistry
|
April 29, 2014
An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?
Clemente Capasso, Claudiu T Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry
|
September 6, 2021
An overview on the recently discovered iota-carbonic anhydrases
Alessio Nocentini, Claudiu T Supuran, Clemente Capasso
The Enzymes
|
October 8, 2025
Sordaria macrospora carbonic anhydrases
Niccolò Paoletti, Claudiu T Supuran, Clemente Capasso
Expert Opinion on Drug Discovery
|
March 14, 2022
Perspectives on the design and discovery of α-ketoamide inhibitors for the treatment of novel coronavirus: where do we stand and where do we go?
Alessio Nocentini, Clemente Capasso, Claudiu T Supuran
Page
of 30